mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.0094 |
0.8 |